Citations for
1BGCI8, JAM2
Biallelic loss-of-function mutations in JAM2 cause primary familial brain calcification.
Cen Z, Chen Y, Chen S, Wang H, Yang D, Zhang H, Wu H, Wang L, Tang S, Ye J, Shen J, Wang H, Fu F, Chen X, Xie F, Liu P, Xu X, Cao J, Cai P, Pan Q, Li J, Yang W, Shan PF, Li Y, Liu JY, Zhang B, Luo W
Brain 2020 Feb 1;143(2):491-502. doi: 10.1093/brain/awz392. 2020
2BGCI8, JAM2
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification
Schottlaender LV, Abeti R, Jaunmuktane Z, et al.
Am J Hum Genet. 2020;106(3):412-421 2020
3JAM2
Somatodendritic Expression of JAM2 Inhibits Oligodendrocyte Myelination.
Redmond SA, Mei F, Eshed-Eisenbach Y, Osso LA, Leshkowitz D, Shen YA, Kay JN, Aurrand-Lions M, Lyons DA, Peles E, Chan JR.
Neuron Aug 17;91(4):824-836. doi: 10.1016/j.neuron.2016.07.021. Epub 2016 Aug 4 2016
4JAM2
Effect of junctional adhesion molecule-2 expression on cell growth, invasion and migration in human colorectal cancer.
Zhao H, Yu H, Martin TA, Zhang Y, Chen G, Jiang WG.
Int J Oncol. Mar;48(3):929-36. doi: 10.3892/ijo.2016.3340. Epub 2016 Jan 15 2016
5JAM2, JAM3
Function of Jam-B/Jam-C interaction in homing and mobilization of human and mouse hematopoietic stem and progenitor cells.
Arcangeli ML, Bardin F, Frontera V, Bidaut G, Obrados E, Adams RH, Chabannon C, Aurrand-Lions M.
Stem Cells Apr;32(4):1043-54. doi: 10.1002/stem.1624 2014
6JAM2, JAM3
Junctional adhesion molecules 2 and 3 may potentially be involved in progression of gastric adenocarcinoma tumors.
Hajjari M, Behmanesh M, Sadeghizadeh M, Zeinoddini M.
Med Oncol. Mar;30(1):380. doi: 10.1007/s12032-012-0380-z. Epub 2013 Jan 1 2013
7JAM2
Junctional adhesion molecule 2 mediates the interaction between hatched blastocyst and luminal epithelium: induction by progesterone and LIF.
Su RW, Jia B, Ni H, Lei W, Yue SL, Feng XH, Deng WB, Liu JL, Zhao ZA, Wang TS, Yang ZM.
PLoS One 7(4):e34325. doi: 10.1371/journal.pone.0034325. Epub 2012 Apr 12. 2012
8JAM2, JAM3
The Junctional Adhesion Molecule-B regulates JAM-C-dependent melanoma cell metastasis.
Arcangeli ML, Frontera V, Bardin F, Thomassin J, Chetaille B, Adams S, Adams RH, Aurrand-Lions M.
FEBS Lett 586(22):4046-51. doi: 10.1016/j.febslet.2012.10.005. Epub 2012 Oct 12. 2012
9JAM2, JAM3
JAM-B regulates maintenance of hematopoietic stem cells in the bone marrow.
Arcangeli ML, Frontera V, Bardin F, Obrados E, Adams S, Chabannon C, Schiff C, Mancini SJ, Adams RH, Aurrand-Lions M.
Blood 118(17):4609-19. doi: 10.1182/blood-2010-12-323972. Epub 2011 Aug 25. 2011
10JAM2, JAM3
Jamb and jamc are essential for vertebrate myocyte fusion.
Powell GT, Wright GJ.
PLoS Biol 9(12):e1001216. doi: 10.1371/journal.pbio.1001216. Epub 2011 Dec 13. 2011
11JAM2, JAM3
Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma.
Tenan M, Aurrand-Lions M, Widmer V, Alimenti A, Burkhardt K, Lazeyras F, Belkouch MC, Hammel P, Walker PR, Duchosal MA, Imhof BA, Dietrich PY.
Glia 58(5):524-37. doi: 10.1002/glia.20941. 2010
12JAM2
Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin.
Ludwig RJ, Hardt K, Hatting M, Bistrian R, Diehl S, Radeke HH, Podda M, Schön MP, Kaufmann R, Henschler R, Pfeilschifter JM, Santoso S, Boehncke WH.
Immunology 128(2):196-205. doi: 10.1111/j.1365-2567.2009.03100.x. 2009
13JAM2
Molecular identification of a retinal cell type that responds to upward motion.
Kim IJ, Zhang Y, Yamagata M, Meister M, Sanes JR.
Nature 452(7186):478-82. doi: 10.1038/nature06739. 2008
14JAM1, JAM2, JAM3
Expression of junctional adhesion molecules on the human lymphatic endothelium.
Ueki T, Iwasawa K, Ishikawa H, Sawa Y.
Microvasc Res 75(2):269-78. Epub 2007 Aug 3. 2008
15F11R, JAM2, JAM3
Novel distribution of junctional adhesion molecule-C in the neural retina and retinal pigment epithelium.
Daniele LL, Adams RH, Durante DE, Pugh EN Jr, Philp NJ.
J Comp Neurol 505(2):166-76. 2007
16JAM2, JAM3
Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation.
Ludwig RJ, Zollner TM, Santoso S, Hardt K, Gille J, Baatz H, Johann PS, Pfeffer J, Radeke HH, Schön MP, Kaufmann R, Boehncke WH, Podda M.
J Invest Dermatol 125(5):969-76. 2005
17JAM1, JAM2, JAM3
The JAM family of junctional adhesion molecules.
Bazzoni G.
Curr Opin Cell Biol 15(5):525-30. Review. 2003
18JAM2, JAM3
Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3.
Liang TW, Chiu HH, Gurney A, Sidle A, Tumas DB, Schow P, Foster J, Klassen T, Dennis K, DeMarco RA, Pham T, Frantz G, Fong S.
J Immunol 168(4):1618-26. 2002
19JAM2
JAM2 interacts with alpha4beta1. Facilitation by JAM3.
Cunningham SA, Rodriguez JM, Arrate MP, Tran TM, Brock TA.
J Biol Chem 277(31):27589-92. 2002
20JAM2
Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion.
Babinska A, Kedees MH, Athar H, Sobocki T, Sobocka MB, Ahmed T, Ehrlich YH, Hussain MM, Kornecki E.
Thromb Haemost 87(4):712-21. 2002
21JAM2
A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions.
Cunningham SA, Arrate MP, Rodriguez JM, Bjercke RJ, Vanderslice P, Morris AP, Brock TA.
J Biol Chem 275(44):34750-6. 2000
22JAM2
Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells.
Palmeri D, van Zante A, Huang CC, Hemmerich S, Rosen SD.
J Biol Chem 275(25):19139-45. 2000